News
In the wake of the toughest funding market in 5 years, IBIS Capital CEO, Charles McIntyre anticipates a cautious recovery in 2024 demanding optimism amid geopolitical uncertainties. Plus, market roundups & industry analyses across …
Dr Michelle Tempest and Marc Kitten, both Partners at healthcare and life sciences consultancy Candesic, explore the excitement around Digital therapeutics (DTx) as an emerging field in healthcare. DTx use technology to deliver evidence-based …
Coverage on STEM education for sustainability and trends that have redefined the healthtech investment landscape. Plus, AI in clinical trial protocol design, the future beyond conventional AI, market roundups & industry analyses across EdTech …
A roundup of the 2023 EdTechX Summit, and a venture capital perspective on AI in Healthcare. Plus, news on the EdTechX Award Winners, how a gynaecological health platform is tackling the gender pain and diagnostics gap, market roundups …
Valentina Milanova, Founder of Daye, joins IBIS Capital Vice President, Bracy Fertig, in an enlightening conversation about her mission to bridge the gender gap in medical research and innovation, specifically for gender pain and …
Benjamin Vedrenne-Cloquet talks to Hichem Omezzine, Partner at TPG Rise, a leading private equity impact investing platform dedicated to addressing global societal challenges. Drawing from his expertise within the healthcare and education sectors across …
IBIS Capital Limited
22 Soho Square
London
W1D 4NS
Tel. +44 (0) 20 7070 7080
Email: info@ibiscap.com
Regulated by the Financial Conduct Authority.
Copyright © 2022 IBIS Capital Limited. All Rights Reserved.